We only market innovative, high-quality products. Period.

 

Over the years, we have built a portfolio of exclusively licensed human medicines and medical devices. Our vision is to build strong, sustainable brands in our markets which requires such exclusivity with our partners for their originator products. A select list of proprietary oligonucleotides for research purposes was developed for our sister company Effimed Research and these are also sold to external customers.
 
Please contact our business development team if you would like to discuss how your product could fit in our strategy.
If you are a distributor or HCP interested in distribution or sales for our products, please sign-up on the contact page.
 
Our global portfolio includes 48 products in major therapeutic categories: